Considerations for medical nutrition therapy management of the critically ill patient with hematological malignancies: A narrative review.
Nutr Clin Pract
; 39(4): 800-814, 2024 Aug.
Article
em En
| MEDLINE
| ID: mdl-38666811
ABSTRACT
Patients with hematological malignancies (HMs) are more frequently admitted now than in the past to the intensive care unit (ICU) due to more aggressive approaches in primary therapy of HMs and the need for critical care support. Pathophysiological alterations derived from HMs and the different hematological therapies, such as chemotherapy, negatively affect gastrointestinal (GI) function, metabolism, and nutrition status. Further, malnutrition strongly influences outcomes and tolerance of the different hematological therapies. In consequence, these critically ill patients frequently present with malnutrition and pathophysiological alterations that create challenges for the delivery of medical nutrition therapy (MNT) in the ICU. Frequent screening, gauging tolerance, and monitoring nutrition status are mandatory to provide individualized MNT and achieve nutrition objectives. The present review discusses how HM impact GI function and nutrition status, the importance of MNT in patients with HM, and specific considerations for guidance in providing adequate MNT to these patients when admitted to the ICU.
Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Estado Nutricional
/
Estado Terminal
/
Neoplasias Hematológicas
/
Cuidados Críticos
/
Desnutrição
/
Terapia Nutricional
/
Unidades de Terapia Intensiva
Limite:
Humans
Idioma:
En
Revista:
Nutr Clin Pract
Ano de publicação:
2024
Tipo de documento:
Article